Horizon Pharma (HZNP) IPO Trades Flat
Tweet
Share
E-mailGet Alerts HZNP Hot Sheet
Join SI Premium – FREE
The IPO for Horizon Pharma, Inc. (Nasdaq: HZNP) is open for trading. Shares are trading at $9.10 after pricing 5.5 million share at $9 per share, below the expected $10-$12 range.
The offering is being made through Stifel Nicolaus Weisel, Cowen and Company, and JMP Securities.
Horizon Pharma a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
The offering is being made through Stifel Nicolaus Weisel, Cowen and Company, and JMP Securities.
Horizon Pharma a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tailored Brands files for IPO on Nasdaq
- CSX (CSX) PT Raised to $46 at TD Cowen
- Scribe Therapeutics Files for Nasdaq IPO
Create E-mail Alert Related Categories
IPOsRelated Entities
Stifel, JMP Securities, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
